Lupin Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$6.6M
Doctors Paid
11,352
Transactions
32,154
2024 Total
$31,529
Payment Breakdown by Category
Research$5.1M (77.4%)
Food & Beverage$544,607 (8.3%)
Consulting$278,413 (4.2%)
Travel$108,332 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5.1M | 1,001 | 77.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $558,408 | 158 | 8.5% |
| Food and Beverage | $544,607 | 30,367 | 8.3% |
| Consulting Fee | $278,413 | 170 | 4.2% |
| Travel and Lodging | $108,332 | 458 | 1.6% |
Payments by Type
Research
$5.1M
1,001 transactions
General
$1.5M
31,153 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, CROSSOVER, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF ONCE DAILY ADMINISTRATION OF LUPIN TIOTROPIUM BROMIDE INHALATION POWDER COMPARED TO SPIRIVA HANDIHALER AND PLACEBO IN PATIENTS WITH COPD INCLUDING A 12-WEEK OPEN LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS | $4.3M | 36 | 774 |
| A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF TWICE DAILY ADMINISTRATION OF FLUTICASONE PROPIONATE 100 MCG AND SALMETEROL XINAFOATE 50 MCG DRY POWDER INHALER COMPARED TO ADMINISTRATION WITH ADVAIR DISKUS 10050 MCG TWICE DAILY AND PLACEBO IN PATIENTS 12 YEARS OF AGE AND OLDER WITH REVERSIBLE PERSISTENT ASTHMA INCLUDING A 3-WEEK OPEN-LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS | $273,500 | 51 | 106 |
| SOLOSEC | $148,912 | 1 | 12 |
| SECWH301 | $113,195 | 0 | 10 |
| IIT Trial- Suppressive Antibacterial Therapy with Once-weekly Secnidazole Granules to Prevent Recurrent Bacterial Vaginosis | $74,000 | 0 | 2 |
| CTA - Secnidazole | $54,276 | 0 | 2 |
| Solosec | $36,000 | 3 | 3 |
| Antiretroviral Pregnancy Registry APR | $27,209 | 6 | 28 |
| In vitro Secnidazole Activity Against Metronidazole-Resistant Trichomonas Vaginalis Isolates | $25,841 | 0 | 1 |
| Trichomonas vaginalis drug sus. Testing 25% | $8,614 | 0 | 1 |
| SEC-WH-301 | $4,475 | 0 | 6 |
| Antiretroviral Pregnancy Registry (APR) | $3,437 | 5 | 56 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2018 |
|---|---|---|---|---|
| Dr. Edward Kerwin, M.d, M.D | Allergy | Medford, OR | $224,313 | $0 |
| Frank Hampel, Md, MD | Allergy & Immunology | New Braunfels, TX | $183,192 | $0 |
| Craig Laforce, M.d, M.D | Allergy & Immunology | Raleigh, NC | $142,190 | $0 |
| Dr. Robert Garver, Md, MD | Pulmonary Disease | Andalusia, AL | $89,490 | $0 |
| Dr. David Schwartz, Md, MD | Obstetrics & Gynecology | Cincinnati, OH | $89,106 | $0 |
| Mr. S David Miller, Md, MD | Allergy & Immunology | North Dartmouth, MA | $85,158 | $0 |
| Jan Westerman | Critical Care Medicine | Jasper, AL | $84,784 | $0 |
| David Pham, Md, MD | Pulmonary Disease | Westminster, CA | $81,742 | $0 |
| Dr. Brian Zeno, M.d, M.D | Specialist | Columbus, OH | $81,338 | $0 |
| Nancy Patel, Do, DO | Internal Medicine | Clinton, SC | $77,309 | $0 |
| Dr. Michael Denenberg, M.d, M.D | Sleep Medicine | Rock Hill, SC | $77,297 | $0 |
| Gregory Feldman, Md, MD | Critical Care Medicine | Columbia, SC | $76,378 | $0 |
| Mr. Robert Nathan, Md, MD | Allergy & Immunology | Colorado Springs, CO | $72,618 | $0 |
| Dr. Leonard Dunn, Md, MD | Pulmonary Disease | Dunedin, FL | $71,913 | $0 |
| Joseph Boscia, Md, MD | Pulmonary Disease | Spartanburg, SC | $64,067 | $0 |
| Ravi Chandran, M.d, M.D | Pulmonary Disease | Tucson, AZ | $64,047 | $0 |
| Unknown Provider | — | — | $62,887 | $0 |
| Dr. Phillip Korenblat, M.d, M.D | Specialist | Saint Louis, MO | $60,717 | $0 |
| Dr. Steven Chavoustie, Md, MD | Gynecology | Miami, FL | $60,210 | $0 |
| Miguel Trevino, Md Pa, MD PA | Internal Medicine | Clearwater, FL | $54,161 | $0 |
| Charles Eubank, M.d, M.D | Gynecology | Corpus Christi, TX | $51,927 | $0 |
| Dr. Angela Scheuerle, M.d, M.D | Clinical Genetics (M.D.) | Dallas, TX | $50,360 | $0 |
| Dr. Amit Patel, Md, MD | Allergy & Immunology | Upland, CA | $50,191 | $0 |
| Evelyne Davidson, Md, MD | Hospice and Palliative Medicine | Knoxville, TN | $48,564 | $0 |
| Charles Fogarty, Md, MD | Pulmonary Disease | Spartanburg, SC | $47,946 | $0 |
Ad
Top Products
- TIOTROPIUM $4.3M
- SOLOSEC $1.6M
Associated Products (6)
- TIOTROPIUM $4.3M
- SOLOSEC $1.6M
- METHERGINE $88,320
- GENERIC $48,583
- SOLOSEC-CEEK $35,759
- SUPRAX $34,147
Payment Categories
- Food & Beverage $544,607
- Consulting $278,413
- Travel & Lodging $108,332
- Research $5.1M
About Lupin Inc.
Lupin Inc. has made $6.6M in payments to 11,352 healthcare providers, recorded across 32,154 transactions in the CMS Open Payments database. In 2024, the company paid $31,529. The top product by payment volume is TIOTROPIUM ($4.3M).
Payments were distributed across 125 medical specialties. The top specialty by payment amount is Obstetrics & Gynecology ($815,944 to 6,970 doctors).
Payment categories include: Food & Beverage ($544,607), Consulting ($278,413), Research ($5.1M), Travel & Lodging ($108,332).
Lupin Inc. is associated with 6 products in the CMS Open Payments database, including TIOTROPIUM, SOLOSEC, and METHERGINE.